In silico Analysis of 3D-QSAR and Molecular Docking for Bcl-2 Inhibitors to Potential Anticancer Drug Development
Ramachandran M, Balwin Nambikkairaj, Kumaran K, Arun Kumar De and G.Ramesh Kumar
DOI: 10.7324/JAPS.2013.31005Pages: 023-029
QSAR and Molecular Docking of Phthalazine Derivatives as Epidermal Growth Factor Receptor (EGFR) Inhibitors
Monika G. Shinde, Siddharth J. Modi, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2017.70427Pages: 181-191
3D-QSAR analysis of pyrimidine derivatives as AXL kinase inhibitors as anticancer agents
Siddharth J. Modi, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2018.81103Pages: 015-027
3D-QSAR, molecular docking, and dynamics simulation of quinazoline–phosphoramidate mustard conjugates as EGFR inhibitor
Ruslin Ruslin, Resky Amelia, Yamin Yamin, Sandra Megantara, Chun Wu, Muhammad Arba
DOI: 10.7324/JAPS.2019.90113Pages: 089-097
3D-QSAR, molecular docking and dynamics simulation of difluorophenol pyridine derivatives as RSK2 inhibitor
Muhammad Arba, Hamzah Azali, Sabarudin Ombe, Alrum Armid, Ida Usman
DOI: 10.7324/JAPS.2019.90601Pages: 001-009
Insights into the structural features of anticancer 1,6-naphthyridines and pyridopyrimidines as VEGFR-2 inhibitors: 3D-QSAR study
Siddharth J. Modi, Dharti H. Modh, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2020.10101Pages: 001-022
In silico studies on pyrazine derivatives for identifying potential inhibitors of PIM-1 kinase
Amena Ali, Abuzer Ali, Mohd. Washid Khan, Abutahir, Ibraheem Husain, Kuldeep Patel, Vivek Asati
DOI: 10.7324/JAPS.2020.10116Pages: 040-049
